Summary
M2 EQUITYBITES-June 10, 2011-Lpath announces new US patent related to its Lipidomics-based drug development programme
(C)1994-2011 M2 COMMUNICATIONS http://www.m2.comSee the full content of this document
Extract
Development Programme
Lpath Inc (OTC.BB:LPTN), a therapeutic antibody company, on Thursday announced the receipt o...
See the full content of this document
Sponsored links
